Dr. Khoury is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 702-732-8831
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Hematopathology, 2002 - 2003
- University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2001 - 2002
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pathology-Anatomic and Clinical, 1997 - 2001
- American University of Beirut Faculty of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 2010 - 2026
- NE State Medical License 2022 - 2026
- TX State Medical License 2011 - 2026
- NV State Medical License 2006 - 2013
- TN State Medical License 2004 - 2013
- OH State Medical License 2000 - 2001
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 70 citationsPharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cellsRaya Saab, Jennifer L. Bills, Alexander P. Miceli, Colleen Anderson, Joseph D. Khoury
Molecular Cancer Therapeutics. 2006-05-01 - 18 citationsp18Ink4c and p53 Act as Tumor Suppressors in Cyclin D1–Driven Primitive Neuroectodermal TumorRaya Saab, Carlos Rodriguez-Galindo, Kelly Matmati, Jerold E. Rehg, Shannon H. Baumer
Cancer Research. 2009-01-15 - 1466 citationsThe 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.Joseph D Khoury, Eric Solary, Oussama Abla, Yassmine Akkari, Rita Alaggio
Leukemia. 2022-07-01
Journal Articles
- CD123 Expression Patterns and Selective Targeting with a CD123-Specific Antibody-Drug Conjugate (IMGN632) in Acute Lymphoblastic LeukemiaL Jeffrey Medeiros, Hagop M Kantarjian, Jeffrey L Jorgensen, Marina Konopleva, Elias J Jabbour, Joseph D Khoury, Sa A Wang, Sergej N Konoplev, Haematologica
- Focal Rosai–Dorfman Disease Coexisting with Lymphoma in the Same Anatomic Site: A Localized Histiocytic Proliferation Associated with MAPK/ERK Pathway ActivationShaoying Li, L Jeffrey Medeiros, Joseph D Khoury, Nature
- Clinicopathologic and Molecular Features in Hairy Cell Leukemia-Variant: Single Institutional ExperienceTariq Muzzafar, L Jeffrey Medeiros, Xinyan Lu, Joseph D Khoury, Nature
Abstracts/Posters
- Efficacy of Targeted Therapy in Novel Pre-Clinical in Vitro and In Vivo Models of Richter Transformation-Diffuse Large B-Cell Lymphoma (RT-DLBCL)Joseph D. Khoury, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcome of Patients (Pts) with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) without 3-Month Complete Molecular Response (CMR)Joseph D. Khoury, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- p53 Mediated Bone Marrow Mesenchymal Stem Cell Expansion Supports Acute Myeloid Leukemia DevelopmentJoseph D. Khoury, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Novel BET Protein Degrader-Based Combinations Exert Lethality Against Human AML Resistant to BET Inhibitors Due to Increased Activity of β-Catenin-TCF7L2- MYC Axis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Chemoimmunotherapy with Inotuzumab Ozogamicin Combined with Mini-Hyper-CVD, with or without Blinatumomab, for Newly Diagnosed Older Patients with Philadelphia Chromoso...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate or High Risk Relapsed/Refractory Myelofibrosis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Remembering Immunology Educator, Researcher Tom McDonald, PhDOctober 7th, 2024
- CAP Releases Updates to Cancer Protocols, Essential for Cancer Reporting and Patient CareJuly 1st, 2021
- Angle PLC Announces Leading US Hematopathologist Appointed as AdvisorNovember 28th, 2018
Grant Support
- Molecular PathologyNational Cancer Institute2007–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: